Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
SM Investments CEO speaks at MAP International CEO Conference in Manila

SM Investments CEO speaks at MAP International CEO Conference in Manila

BitgetBitget2026/09/30 03:06
  • SM Investments highlighted long-term investment discipline at the 24th MAP International CEO Conference in Pasay City on Sept. 29, 2026.
  • CEO Frederic C. DyBuncio pointed to rising regional incomes as a key demand shift, urging expansion beyond Metro Manila.
  • Executives discussed AI and data as tools to spot durable trends faster, while stressing leadership judgment on capital allocation timing.
  • The group reiterated a model where retail, banking, property, and portfolio units self-fund growth while paying dividends to the parent.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SM Investments Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609292305PR_NEWS_USPR_____CN60150) on September 30, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly

The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.

智通财经•2026/10/13 02:41

Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results

Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.

智通财经•2026/10/13 01:56